- ►prsjournal.com [PDF] G Mojica, SM Hariprasad, RD Jager, WF … - British Medical Journal, 2008 - bjo.bmj.com COMMENT In this patient with intermediate uveitis (pars planitis), the clinical
and electrophy- siological findings also suggest the additional diagnosis of
AZOOR, which presents with bilateral asymmetric progressive field loss, ... Cited by 2 - Related articles - All 4 versions
[CITATION] the Pan American Collaborative Retina Group: Twelve-month safety of intravitreal …
L Wu, MA Martínez-Castellanos, H Quiroz- … - Graefes Arch Clin Exp Ophthalmol, 2008 Cited by 3 - Related articles
M Inatani, K Iwao, T Kawaji, Y Hirano, Y … - American Journal of Ophthalmology, 2008 - Elsevier PURPOSE: To determine the risk factors for intraocular pressure (IOP) elevation
after the injection of triamcinolone acetonide (TA). DESIGN: Retrospective
interventional case-control study. METHODS: setting: Multicenter. patient ... Cited by 5 - Related articles - All 10 versions
SJ Bakri, CA McCannel, AO Edwards, DM … - Graefe's Archive for Clinical and Experimental …, 2008 - Springer Abstract Background To describe the occurrence of ocular hyper- tension in four
patients following injection of ranibizumab intravitreally. Methods Case series.
Results Four patients had high intraocular pressure after intravitreal ... Cited by 5 - Related articles - BL Direct - All 3 versions
A Jalil, C Fenerty, S Charles - Eye (London, England), 2007 - ncbi.nlm.nih.gov 1: Eye. 2007 Dec;21(12):1541. Epub 2007 Oct 26. Intravitreal bevacizumab
(Avastin) causing acute glaucoma: an unreported complication. ... Cited by 5 - Related articles - BL Direct - All 4 versions
M Shinzato, Y Yamashiro, N Miyara, A … - Ophthalmic Res, 2007 - content.karger.com Treatment with glucocorticoids such as dexametha- sone (DEX) induces ocular
hypertension, that is, eleva- tion of intraocular pressure (IOP), both in vivo
and in perfusion-cultured eyes [1–3] . Thus, a subset of patients treated ... Cited by 5 - Related articles - BL Direct - All 4 versions
SJ Bakri, JS Pulido, CA McCannel, DO Hodge, … - Eye, 2007 - nature.com A total of 212 injections were performed (76 bevacizumab in 63 patients, 42
triamcinolone in 41 patients, 94 pegaptanib in 74 patients). At 10 min, over 87%
of eyes receiving each drug had an IOP of less than 35 mmHg. Three of the ... Cited by 7 - Related articles - All 4 versions
K Kotliar, M Maier, S Bauer, N Feucht, C … - Acta Ophthalmologica Scandinavica, 2007 - duanesolution.com Methods: A biomechanical model relying on 3-dimensional elasticity theory was
developed to determine the short-term effect of volume changes on IOP. We
calculated the effect for intravitreal injections of 0.1 ml in myopic, ... Cited by 7 - Related articles - Cached - BL Direct - All 6 versions
… PG NEHEMY, AP SCHACHAT, MB NEHEMY - Retina, 2008 - journals.lww.com Conclusions: A 4-mg IVTA injection was associated with SOH in 32.0% of treated
eyes. The risk of SOH was higher in eyes with previous glaucoma and higher
baseline IOP. Peak IOP after IVTA injection was lower in vitrectomized ... Cited by 7 - Related articles - BL Direct - All 4 versions
